RapidAI Earns FDA Clearance for Rapid Aortic, Bringing AI-Driven Aortic Measurements and Surveillance to Care Teams
New deep clinical AI solution sets a higher standard for deep clinical AI in aortic patient care SAN MATEO, Calif. — November 18, 2025 — RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced U.S. Food and Drug Administration (FDA) clearance of Aortic Management, part of the Rapid Aortic product, a […]






